1) Tongsaimai Pellets intermediate products
通塞脉微丸中间体
1.
999 9),the average amount range of general flavones in Tongsaimai Pellets was 17%~21%,while the average amount range of general flavones in Tongsaimai Pellets intermediate products was 27%~29%.
999 9),通塞脉微丸总黄酮的含量范围在17%~21%之间;通塞脉微丸中间体总黄酮的含量范围在27%~29%之间。
2.
702 mg, the average amount range of general saponins in Tongsaimai pellets was 46%～48%, while the average amount range of general saponins in Tongsaimai pellets intermediate products was 67%～70%.
通塞脉微丸中间体总皂苷的含量范围在67%～70%之间。
2) Tongsaimai pellets
通塞脉微丸
1.
HPCE determination of liquiritin,liquiritigenin and ferulic acid in Tongsaimai pellets
HPCE法测定通塞脉微丸中甘草苷、甘草素和阿魏酸的含量
2.
Objective To determine the content of general flavones in Tongsaimai pellets and its intermediate products.
目的测定通塞脉微丸及中间体中总黄酮的含量。
3.
Objective To determine the content of general saponins in Tongsaimai pellets and its intermediate products.
目的测定通塞脉微丸及中间体中总皂苷的含量。
3) TONG SAIMAI PELLETS/chemistry
通塞脉微丸/化学
4) Qiangxin Tongmai pills
强心通脉微丸
1.
Objective:To study the effection of Qiangxin Tongmai pills on heart function and serum cell factor in treating chronic heart failure patients.
目的:探讨强心通脉微丸对慢性心力衰竭(CHF)患者心功能和血清细胞因子含量的影响。
5) Naosaitong pills
脑塞通丸
1.
Objective:To set up a method to determine the Ginsenoside Rg_1,Ginsenoside Re,Ginsenoside Rb_1 in Naosaitong pills.
目的:建立脑塞通丸的含量测定方法。
6) pulsatile pellets
脉冲微丸
1.
OBJECTIVE To investigate release behavior of sotalol hydrochloride pulsatile pellets in vitro,and to realize pulsatile release mechanism and optimize formulation.
目的研究盐酸索他洛尔脉冲微丸的体外释放特性,根据本类脉冲释放曲线的关键点的比较指导处方优化。
补充资料：通塞
1.谓境遇之顺逆。 2.通畅与阻塞。 3.指诗文的通顺与艰涩。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条